Quantessence Capital’s Enovis ENOV Stock Holding History

Quantessence Capital’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,013	Closed	-$650K	–	265
2025 Q1	$650K	Buy	+17,013	New	+$722K	0.16%	163

Other funds holding ENOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

DAM

Dorsey Asset Management Chicago, Illinois $1.26B AUM 18.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Quantessence Capital's ENOV Position: Q2 2025 in Review

Quantessence Capital sold out of Enovis (ENOV) in Q2 2025, closing a stake of 17,013 shares — an estimated $650K sold.

Quantessence Capital first reported a position in ENOV in Q1 2025 and held it in 1 quarter. The position peaked at $650K in Q1 2025. 285 funds tracked by Wall St. Rank hold ENOV as of Q2 2025.

Quantessence Capital reported no remaining Enovis position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 17,013 Enovis shares in Q2 2025, an estimated $650K.
Quantessence Capital first reported a position in Enovis in Q1 2025 and held it in 1 quarter.
Quantessence Capital's Enovis position peaked at $650K in Q1 2025.
285 funds tracked by Wall St. Rank held Enovis as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.